NA (CAPN)
(Real Time Quote from BATS)
$0.71 USD
+0.01 (1.44%)
Updated May 11, 2017 03:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Soleno Therapeutics, Inc. [CAPN]
Reports for Purchase
Showing records 1 - 7 ( 7 total )
Company: Soleno Therapeutics, Inc.
Industry: Medical - Instruments
Company: Soleno Therapeutics, Inc.
Industry: Medical - Instruments
Merger Timeline, 8K and S1 Registration Statement
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: GRISEWOOD S
Company: Soleno Therapeutics, Inc.
Industry: Medical - Instruments
Merger with Private Rare Disease Company Announced, Business Focus Changes to Rare Disease Therapeutics
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: GRISEWOOD S
Company: Soleno Therapeutics, Inc.
Industry: Medical - Instruments
Suspended research coverage due to the termination or loss of the primary and/or secondary analysts responsible for coverage.
Provider: DAWSON JAMES SECURITIES, INC.
Company: Soleno Therapeutics, Inc.
Industry: Medical - Instruments
ValuEngine Detailed Valuation Report for CAPN
Provider: ValuEngine, Inc
Company: Soleno Therapeutics, Inc.
Industry: Medical - Instruments
Capnia made significant progress in 2015 in a number of areas, including product marketing
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: Soleno Therapeutics, Inc.
Industry: Medical - Instruments
We are initiating coverage on CAPN shares with a BUY rating and 12-18 month price target of $12.70 per share
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
|